NIMS first clinical trials of Covid19 Vaccine was Successful
hyderabad sources stated that the Nizams Institute of Medical Sciences (NIMS) first step towards clinical trials of the COVID-19 vaccine was successful. As part of India's first coronavirus vaccine COVAXIN clinical trials, NIMS in hyderabad has administered the first dose of vaccine to two volunteers on monday, July 20. NIMS doctors will administer COVAXIN vaccine to two more volunteers on wednesday, July 22.
NIMS doctors said the condition of two volunteers were stable and they were discharged on Tuesday. The health condition of the two volunteers will be monitored for 14 days, said COVAXIN clinical trials principal investigator, assistant professor Dr C prabhakar Reddy. Volunteers will be monitored daily by phone and video calls, after 14 days they will be brought back to the hospital to collect their blood samples and get them tested, said Prabhakar.
Doctors said that they will monitor the extent to which antibodies have been developed in the volunteer's body due to the inactivated virus and if there are any problems. Doctors at the NIMS clinical and pharmacology department are delighted that the first attempt of the human clinical trial of the COVAXIN vaccine has been successful. Moreover as part of the clinical trials, NIMS doctors sent blood samples from 13 volunteers to an ICMR approved lab in Delhi. It is learned that eight of them have been issued fitness certificates. NIMS doctors will administer COVAXIN vaccine to two more volunteers on wednesday, based on these certificates. With this, the number of volunteers who were injected with the vaccine will reach four.